Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ducreux

Showing results (11-20 of 274) with videos related to

Pageof 28
Sort By:
Gastroenterologie Clinique Et Biologique|January 1, 1996
[Adjuvant therapy of cancer of the rectum]M Ducreux, R Coquard
La Revue De Medecine Interne|January 1, 1997
[Recent advances in adjuvant chemotherapy in colonic cancers]M Ducreux, P Rougier
ESMO Open|January 26, 2025
ESMO Clinical Practice Guideline interim update on the management of biliary tract cancerA Vogel, M Ducreux,
Bulletin Du Cancer|March 21, 2001
[Prevention and treatment of chemotherapy-induced digestive toxicities]V Boige, M Ducreux
The Journal of Infusional Chemotherapy|October 1, 1996
The French experience with infusional 5-FU in gastric and pancreatic cancerM Ducreux, P Rougier
The New England Journal of Medicine|February 24, 2001
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancerJ P Pignon, M Ducreux
Presse Medicale (Paris, France : 1983)|February 28, 2002
[The new chemotherapy of colorectal cancers]J Taïeb, V Boige, M Ducreux
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2024
Reply to the Letter to the Editor 'Radiation therapy for locally advanced pancreatic adenocarcinoma: a therapeutic option which should not be forgotten' (in regard to "Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up") by Huguet et alT Conroy, K Haustermans, M Ducreux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2021
Selecting the right chemotherapy in first-line advanced squamous cell carcinoma of the anusM Ducreux, S Kim, C Borg
Bulletin Du Cancer|February 5, 1999
[Second-line irinotecan chemotherapy in the treatment of metastatic colorectal cancers: phase III trials]E Mitry, M Ducreux, P Rougier
Pageof 28

Showing results (11-20 of 274) with videos related to

Sort By:
Pageof 28
Gastroenterologie Clinique Et Biologique|January 1, 1996
[Adjuvant therapy of cancer of the rectum]M Ducreux, R Coquard
La Revue De Medecine Interne|January 1, 1997
[Recent advances in adjuvant chemotherapy in colonic cancers]M Ducreux, P Rougier
ESMO Open|January 26, 2025
ESMO Clinical Practice Guideline interim update on the management of biliary tract cancerA Vogel, M Ducreux,
Bulletin Du Cancer|March 21, 2001
[Prevention and treatment of chemotherapy-induced digestive toxicities]V Boige, M Ducreux
The Journal of Infusional Chemotherapy|October 1, 1996
The French experience with infusional 5-FU in gastric and pancreatic cancerM Ducreux, P Rougier
The New England Journal of Medicine|February 24, 2001
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancerJ P Pignon, M Ducreux
Presse Medicale (Paris, France : 1983)|February 28, 2002
[The new chemotherapy of colorectal cancers]J Taïeb, V Boige, M Ducreux
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2024
Reply to the Letter to the Editor 'Radiation therapy for locally advanced pancreatic adenocarcinoma: a therapeutic option which should not be forgotten' (in regard to "Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up") by Huguet et alT Conroy, K Haustermans, M Ducreux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2021
Selecting the right chemotherapy in first-line advanced squamous cell carcinoma of the anusM Ducreux, S Kim, C Borg
Bulletin Du Cancer|February 5, 1999
[Second-line irinotecan chemotherapy in the treatment of metastatic colorectal cancers: phase III trials]E Mitry, M Ducreux, P Rougier
Pageof 28